What is Touch Bionics?
Össur Touch Solutions, operating as Touch Bionics, is at the forefront of developing sophisticated prosthetic solutions for individuals facing upper limb deficiencies. Their product portfolio encompasses advanced myoelectric prosthetic hands, partial hand solutions, and highly realistic passive silicone prostheses, all designed to improve user functionality and quality of life. The company distinguishes itself by offering comprehensive training and clinical support services, alongside valuable resources for new amputees and a network to connect them with certified practitioners. This focus on user experience and support underscores their commitment to innovation in the field of advanced prosthetics and bionic devices.
How much funding has Touch Bionics raised?
Touch Bionics has raised a total of $11.5M across 4 funding rounds:
Multiple Rounds
$7.7M
Unspecified
$3.9M
Unspecified (2010): $1.3M with participation from Archangels
Debt (2010): $2.5M led by Clydesdale Bank
Other Financing Round (2010): $3.9M supported by Clydesdale Bank
Unspecified (2011): $3.9M featuring Archangel Investors Limited and Scottish Venture Fund
Key Investors in Touch Bionics
Clydesdale Bank
Clydesdale Bank, a prominent UK financial institution, has provided debt financing to Touch Bionics, indicating a role in supporting the company's operational and expansionary capital needs through traditional lending.
Archangel Investors Limited
Archangel Investors Limited, a key backer, has participated in multiple funding rounds, suggesting a strategic interest in early-stage and growth-stage technology companies, likely focusing on innovative medical device sectors.
Scottish Venture Fund
The Scottish Venture Fund, managed by Scottish Enterprise, a national economic development agency, has invested in Touch Bionics, signaling support for Scottish-based innovative companies with high growth potential in specialized technology markets.
What's next for Touch Bionics?
With a history of securing substantial investment, Touch Bionics is positioned for continued expansion and technological advancement in the prosthetics sector. The recent major strategic investment indicates a strong confidence from backers in the company's trajectory and market potential. This capital infusion is likely to fuel further research and development into next-generation bionic limbs, enhance manufacturing capabilities, and broaden their global market reach. The company's strategic focus on user-centric solutions and comprehensive support services, combined with ongoing technological innovation, suggests a path towards solidifying its leadership in the advanced prosthetic technology landscape.
See full Touch Bionics company page
